Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

3.13
Delayed Data
As of Jun 24
 -0.19 / -5.72%
Today’s Change
3.12
Today|||52-Week Range
19.43
-76.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues12.6M14.9M18.0M19.7M
 
 
 
 
 
Depreciation And Amortization1.3M1.1M1.3M1.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses36.4M42.3M45.0M45.9M
 
 
 
 
 
Research And Development30.4M35.1M38.2M36.1M
 
 
 
 
 
Total Operating Expenses37.7M43.5M46.3M47.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.1M-28.6M-28.2M-27.6M
 
 
 
 
 
Interest Expense On Debt5.4M5.1M5.1M5.0M
 
 
 
 
 
Other Expenses16.0K-38.0K-4.0K551.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.5M-33.7M-33.2M-31.9M
 
 
 
 
 
Net Income-30.5M-33.7M-33.2M-31.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS86.3M86.8M87.0M87.0M
 
 
 
 
 
Shares To Calculate EPS Diluted86.3M86.8M87.0M87.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.39-$0.38-$0.37
 
 
 
 
 
EPS Diluted-$0.35-$0.39-$0.38-$0.37